NCT07641296

Evaluation of the Safety, Efficacy, Dose Response of the Bimatoprost Drug Ring System (BIM-DRS) in Pseudophakic Patients Diagnosed With Open Angle Glaucoma or Ocular Hypertension

RecruitingPHASE1INTERVENTIONAL

Trial Details

Start: 2026-07-31Est. Completion: 2027-02-28

Enrollment target: 24 participants

Contact

Sr. Vice President, Clinical Developmentclinical@spyglasspharma.com 949-284-6904

Macular Diseases

In just a few years, intravitreal injections have become a standard method of administration for certain retinal desease…

Toulon, FranceEst. completion Jul 2028

Glaucoma, Primary Open Angle

Evaluation of the safety and effectiveness of the ELIOS System procedure to reduce intraocular pressure (IOP) in adult s…

Glendale, United StatesCompleted Jul 29, 2025

Open Angle Glaucoma

As part of the post-market clinical follow-up (PMCF), this registry is developed to ensure real-world data collection on…

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.